Fluticasone-Associated Churg-Strauss Syndrome;Amiodarone-Induced Lipomas;Amiodarone-Induced Pulmonary Toxicity;Hyperchloremic Metabolic Acidosis Resulting from Topiramate Use;Generalized Seizure in Patient Receiving Epidural Meperidine;Sirolimus-Induced Pneumonitis;Inappropriate Benzodiazepine Use and the Risk of Fracture;Chemotherapy-Induced Nausea and Vomiting
Restricted accessResearch articleFirst published online October, 2008
Fluticasone-Associated Churg-Strauss Syndrome;Amiodarone-Induced Lipomas;Amiodarone-Induced Pulmonary Toxicity;Hyperchloremic Metabolic Acidosis Resulting from Topiramate Use;Generalized Seizure in Patient Receiving Epidural Meperidine;Sirolimus-Induced Pneumonitis;Inappropriate Benzodiazepine Use and the Risk of Fracture;Chemotherapy-Induced Nausea and Vomiting
The purpose of this feature is to heighten awareness of specific adverse drug reactions (ADRs), discuss methods of prevention, and promote reporting of ADRs to the US Food and Drug Administration's (FDA's) MedWatch program (800-FDA-1088). If you have reported an interesting, preventable ADR to MedWatch, please consider sharing the account with our readers.
Get full access to this article
View all access options for this article.
References
1.
BeersM.H.Explicit criteria for determining potentially inappropriate medication use by the elderly. An update. Arch Intern Med.1997; 157(14): 1531–1536.
